Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.57K | Sales 2023 | 555 364.72 | Capitalization | 39.72M 26.1M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.77M | Net income 2023 | -20M -13.14M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.84M | Net cash position 2023 | 3.44M 2.26M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |